Literature DB >> 8432287

Evidence for biventricular involvement in acromegaly: a Doppler echocardiographic study.

S Fazio1, A Cittadini, D Sabatini, B Merola, A M Colao, B Biondi, G Lombardi, L Saccá.   

Abstract

To investigate left and right ventricular involvement in acromegaly, 20 patients were studied by Doppler echocardiography. Nine of them had systemic hypertension. Right ventricular free wall thickness was significantly increased in acromegalic patients (8 +/- 2 vs 4 +/- 1 mm; P < 0.001). Left ventricular mass index was augmented both in the whole group and in the subgroup of normotensive acromegalics, as compared with normals (134 +/- 33 and 115 +/- 20 vs 80 +/- 18 g.m-2; P < 0.01). Ejection phase indices were normal in the patient group, while impaired left and right ventricular diastolic filling was found. In fact isovolumic relaxation time was prolonged (118 +/- 21 vs 78 +/- 12 ms; P < 0.001), ratio of early to late mitral (0.9 +/- 0.3 vs 1.8 +/- 0.5; P < 0.001) and tricuspid (1.0 +/- 0.2 vs 1.4 +/- 0.3; P < 0.001) flow velocities were significantly decreased as compared with controls. Superior vena cava flowmetry was also abnormal showing a marked decrease of diastolic filling wave and, consequently, of the ratio between peak diastolic and peak systolic flow velocity. No significant differences were observed between normotensive and hypertensive acromegalics, except for left ventricular mass index (115 +/- 20 vs 156 +/- 31 g.m-2; P < 0.01). These findings indicate that abnormal diastolic filling patterns of transmitral, transtricuspid, and superior vena cava flowmetry suggesting 'impaired relaxation' associated with increased left and right ventricular mass, frequently occur in acromegaly.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8432287     DOI: 10.1093/eurheartj/14.1.26

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  18 in total

1.  Incidence of myocardial infarction and stroke in acromegaly patients: results from the German Acromegaly Registry.

Authors:  Christof Schöfl; David Petroff; Anke Tönjes; Martin Grussendorf; Michael Droste; Günter Stalla; Cornelia Jaursch-Hancke; Sylvère Störmann; Jochen Schopohl
Journal:  Pituitary       Date:  2017-12       Impact factor: 4.107

2.  Quantifying subtle changes in cardiovascular mechanics in acromegaly: a Doppler myocardial imaging study.

Authors:  R Jurcut; S Găloiu; A Florian; A Vlădaia; O R Ioniţă; M S Amzulescu; I Baciu; B A Popescu; M Coculescu; C Ginghina
Journal:  J Endocrinol Invest       Date:  2014-08-15       Impact factor: 4.256

3.  Acromegalic cardiomyopathy: evaluation of the left ventricular diastolic function in the subclinical stage.

Authors:  N Ozbey; A Oncül; Z Buğra; A Vural; F Erzengin; Y Orhan; K Büyüköztürk; E Sencer; S Molvalilar
Journal:  J Endocrinol Invest       Date:  1997-06       Impact factor: 4.256

Review 4.  Acromegalic cardiomyopathy: Epidemiology, diagnosis, and management.

Authors:  Ajay N Sharma; Marilyn Tan; Ezra A Amsterdam; Gagan D Singh
Journal:  Clin Cardiol       Date:  2018-03-25       Impact factor: 2.882

5.  Renin-Angiotensin System Blockade Improves Cardiac Indices in Acromegaly Patients.

Authors:  Julia D J Thomas; Abhishek Dattani; Filip Zemrak; Thomas Burchell; Scott A Akker; Felicity J L Kaplan; Bernard Khoo; Simon Aylwin; Ashley B Grossman; L Ceri Davies; Márta Korbonits
Journal:  Exp Clin Endocrinol Diabetes       Date:  2017-02-06       Impact factor: 2.949

6.  Cardiovascular effects of a single slow release lanreotide injection in patients with acromegaly and left ventricular hypertrophy.

Authors:  F Manelli; P Desenzani; E Boni; G Bugari; F Negrini; G Romanelli; V Grassi; A Giustina
Journal:  Pituitary       Date:  1999-11       Impact factor: 4.107

Review 7.  Role of growth hormone in chronic heart failure. Therapeutic implications.

Authors:  M Volterrani; F Manelli; M Cicoira; R Lorusso; A Giustina
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

8.  The GH/IGF-1 Axis and Heart Failure.

Authors:  Graziella Castellano; Flora Affuso; Pasquale Di Conza; Serafino Fazio
Journal:  Curr Cardiol Rev       Date:  2009-08

9.  Improvement of left ventricular hypertrophy and arrhythmias after lanreotide-induced GH and IGF-I decrease in acromegaly. A prospective multi-center study.

Authors:  G Lombardi; A Colao; P Marzullo; B Biondi; E Palmieri; S Fazio
Journal:  J Endocrinol Invest       Date:  2002-12       Impact factor: 4.256

Review 10.  Acromegalic cardiomyopathy: a review of the literature.

Authors:  M P Matta; P Caron
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.